Search Results for "Immuno Concepts Na Ltd"
Original Source: Immuno Concepts N.A. Ltd.
Immuno Concepts was founded in 1979 with a commitment to advance the quality of diagnostic assays for systemic rheumatic diseases. Over twenty years later we still honor that commitment. Our company motto, "Quality People Setting the Quality Standard," further reflects this commitment. We are proud to display that we have a quality system that is certified to ISO 9001 and we are actively pursuing CE mark certification for our products. In 1979 Immuno Concepts pioneered the conversion from rodent tissue to H...
Matching Channels
Alternative Medicine - news, reports, trials and publications
Traditional Chinese Medicine (simplified Chinese: 中医; traditional Chinese: 中醫; pinyin: zhōng yī: "Chinese Medicine") refers to a broad range of medicine practices sharing common...
Roche is the 5th largest pharmaceutical company in the world, based on annual sales, which were recorded at $36,017m in 2009. The pharmaceutical products of Roche are major players in the followin...
Ulcerative colitis is a disease that affects around 120,000 people in the UK and causes inflammation of the large intestine - or colon. Symptoms vary in severity from pain and discomfort, through mu...
Matching News
Bristol-Myers Squibb forms International Immuno-Oncology Network
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientifi...
BMS joins with cancer research institutions to advance science of immuno-oncology
Bristol-Myers Squibb (BMS) has formed the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to advance the scientific understanding of immun...
BMS announces global collaboration for immuno-oncology
Global biopharmaceutical company Bristol-Myers Squibb has announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims t...
BMS forms international industry-academe immuno-oncology consortium
Bristol-Myers Squibb has completed the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understa...
BMS launches global collaboration with academia to advance immuno-oncology
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientifi...
Bristol-Myers Squibb announces formation of International Immuno-Oncology Network (II-ON)
Bristol-Myers Squibb announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understandin...
Galapagos reaches milestone in immuno-inflammation alliance with GSK
Galapagos has reached a milestone in its immuno-inflammation alliance with GlaxoSmithKline (GSK) by delivering a fifth pre-clinical drug candidate.
BMS forms immuno-oncology collaboration with 10 US and EU cancer institutes
Bristol-Myers Squibb (BMS) formed the International Immuno-Oncology Network (II-ON) with 10 research centers in the US and EU as a global collaboration between industry and academia to broaden global...
Matching PubMed Articles
Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody Therapy.
Summation Monoclonal antibodies (mAbs) have been approved for therapeutic use in a broad range of medical indications, especially in oncology, and are forming the most rapidly expanding category of ph...
BACKGROUND: Immuno-cell therapy using activated lymphocytes (ALs) and/or dendritic cells (DCs) is considered one of the less toxic supportive therapies compared with conventional chemotherapy and radi...
Evaluation of the Content Coverage of SNOMED CT Representing ICNP Seven-axis Version 1 Concepts.
Objectives: The purpose of this study is to evaluate the ability of SNOMED CT (Systematized Nomenclature of Medicine Clinical Terms) to represent the concepts of the ICNP version 1 - the seven-axis m...
Due to the specific habitat conditions in which they live, earthworms are constantly exposed to pathogens. Consequently, they have evolved various immuno-defense mechanisms, including cellular (coelom...
An ICF-CY-based content analysis of the Vineland Adaptive Behavior Scales-II.
Background The International Classification of Functioning, Disability and Health (ICF), and its version for children and youth (ICF-CY), has been increasingly adopted as a system to describe function...
